| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/26/2023 | T2 Biosystems, Inc. | TTOO | Sale | Common Stock | 2.2M | $0.20 | $432.9k | By CRG Partners III L.P. | 09/26/2023 |
| 09/26/2023 | T2 Biosystems, Inc. | TTOO | Sale | Common Stock | 1.3M | $0.20 | $269.5k | By CRG Partners III ? Parallel Fund ?A? L.P. | 09/26/2023 |
| 09/26/2023 | T2 Biosystems, Inc. | TTOO | Sale | Common Stock | 431.3k | $0.20 | $86.6k | By CRG Partners III (Cayman) Unlev AIV I L.P. | 09/26/2023 |
| 09/26/2023 | T2 Biosystems, Inc. | TTOO | Sale | Common Stock | 1.5M | $0.20 | $293.4k | By CRG Partners III (Cayman) Lev AIV I L.P. | 09/26/2023 |
| 09/25/2023 | T2 Biosystems, Inc. | TTOO | Sale | Common Stock | 67.8k | $0.25 | $16.9k | By CRG Partners III (Cayman) Lev AIV I L.P. | 09/25/2023 |
| 09/25/2023 | T2 Biosystems, Inc. | TTOO | Sale | Common Stock | 20k | $0.25 | $5k | By CRG Partners III (Cayman) Unlev AIV I L.P. | 09/25/2023 |
| 09/25/2023 | T2 Biosystems, Inc. | TTOO | Sale | Common Stock | 62.3k | $0.25 | $15.6k | By CRG Partners III ? Parallel Fund ?A? L.P. | 09/25/2023 |
| 09/25/2023 | T2 Biosystems, Inc. | TTOO | Sale | Common Stock | 100k | $0.25 | $25k | By CRG Partners III L.P. | 09/25/2023 |
| 09/22/2023 | T2 Biosystems, Inc. | TTOO | Sale | Common Stock | 2M | $0.26 | $525.7k | By CRG Partners III L.P. | 09/22/2023 |
| 09/22/2023 | T2 Biosystems, Inc. | TTOO | Sale | Common Stock | 1.3M | $0.26 | $327.4k | By CRG Partners III ? Parallel Fund ?A? L.P. | 09/22/2023 |
| 09/22/2023 | T2 Biosystems, Inc. | TTOO | Sale | Common Stock | 406.3k | $0.26 | $105.1k | By CRG Partners III (Cayman) Unlev AIV I L.P. | 09/22/2023 |
| 09/22/2023 | T2 Biosystems, Inc. | TTOO | Sale | Common Stock | 1.4M | $0.26 | $356.3k | By CRG Partners III (Cayman) Lev AIV I L.P. | 09/22/2023 |
| 08/04/2023 | Avinger Inc | AVGR | Grant | Series E Convertible Preferred Stock | 166.08 | $0.72 | $118.7 | By CRG Partners III ? Parallel Fund (A) L.P. | 08/04/2023 |
| 08/04/2023 | Avinger Inc | AVGR | Grant | Series E Convertible Preferred Stock | 309.696 | $0.72 | $221.4 | By CRG Partners III L.P. | 08/04/2023 |
| 08/04/2023 | Avinger Inc | AVGR | Grant | Series E Convertible Preferred Stock | 658.176 | $0.72 | $470.6 | By CRG Partners III (Cayman) Lev AIV I L.P. | 08/04/2023 |
| 08/04/2023 | Avinger Inc | AVGR | Grant | Series E Convertible Preferred Stock | 53.376 | $0.72 | $38.2 | By CRG Partners III (Cayman) Unlev AIV I L.P. | 08/04/2023 |
| 08/04/2023 | Avinger Inc | AVGR | Grant | Series E Convertible Preferred Stock | 732.672 | $0.72 | $523.9 | By CRG Partners III Parallel Fund (B) (Cayman) L.P. | 08/04/2023 |
| 07/03/2023 | T2 Biosystems, Inc. | TTOO | Grant | Common Stock | 19.3M | $0.00 | $0 | By CRG Partners III L.P. | 07/03/2023 |
| 07/03/2023 | T2 Biosystems, Inc. | TTOO | Grant | Common Stock | 12M | $0.00 | $0 | By CRG Partners III ? Parallel Fund ?A? L.P. | 07/03/2023 |
| 07/03/2023 | T2 Biosystems, Inc. | TTOO | Grant | Common Stock | 3.9M | $0.00 | $0 | By CRG Partners III (Cayman) Unlev AIV I L.P. | 07/03/2023 |
| 07/03/2023 | T2 Biosystems, Inc. | TTOO | Grant | Common Stock | 13.1M | $0.00 | $0 | By CRG Partners III (Cayman) Lev AIV I L.P. | 07/03/2023 |
| 07/03/2023 | T2 Biosystems, Inc. | TTOO | Grant | | 33.6k | $0.07 | $2.4k | By CRG Partners III (Cayman) Lev AIV I L.P. | 07/03/2023 |
| 07/03/2023 | T2 Biosystems, Inc. | TTOO | Grant | | 59.7k | $0.07 | $4.2k | By CRG Partners III Parallel Fund (B) (Cayman) L.P. | 07/03/2023 |
| 12/24/2020 | Assertio Holdings, Inc. | ASRT | Sale | Common Stock | 2M | $0.37 | $730.1k | By Loan Security Holdings I LLC | 12/23/2020 |
| 12/23/2020 | Assertio Holdings, Inc. | ASRT | Sale | Common Stock | 6.8M | $0.37 | $2.5M | By Loan Security Holdings I LLC | 12/23/2020 |
| 12/22/2020 | Assertio Holdings, Inc. | ASRT | Sale | Common Stock | 1.5M | $0.34 | $508.5k | By Loan Security Holdings I LLC | 12/18/2020 |
| 12/21/2020 | Assertio Holdings, Inc. | ASRT | Sale | Common Stock | 500k | $0.36 | $180.1k | By Loan Security Holdings I LLC | 12/18/2020 |
| 12/18/2020 | Assertio Holdings, Inc. | ASRT | Sale | Common Stock | 500k | $0.38 | $188.8k | By Loan Security Holdings I LLC | 12/18/2020 |
| 05/20/2020 | Zyla Life Sciences | ZCOR | Disposition | Common Stock | 4.6M | $0.00 | $0 | By Loan Security Holdings I LLC | 05/20/2020 |
| 05/20/2020 | Zyla Life Sciences | ZCOR | Disposition | Warrants | 2.4M | $0.00 | $243.6 | By Loan Security Holdings I LLC | 05/20/2020 |
| 09/30/2019 | Valeritas Holdings Inc. | VLRX | Purchase | Series B Convertible Preferred Stock | 1.7M | $0.00 | $0 | By Capital Royalty Partners II L.P. | 09/30/2019 |
| 09/30/2019 | Valeritas Holdings Inc. | VLRX | Purchase | Series B Convertible Preferred Stock | 1.9M | $0.00 | $0 | By Capital Royalty Partners II ? Parallel Fund ?A? L.P. | 09/30/2019 |
| 09/30/2019 | Valeritas Holdings Inc. | VLRX | Purchase | Series B Convertible Preferred Stock | 3.1M | $0.00 | $0 | By Parallel Investment Opportunity Partners II L.P. | 09/30/2019 |
| 09/30/2019 | Valeritas Holdings Inc. | VLRX | Purchase | Series B Convertible Preferred Stock | 8.2M | $0.00 | $0 | By Capital Royalty Partners II ? Parallel Fund ?B? (Cayman) L.P. | 09/30/2019 |
| 09/30/2019 | Valeritas Holdings Inc. | VLRX | Purchase | Series B Convertible Preferred Stock | 602.5k | $0.00 | $0 | By Capital Royalty Partners II (Cayman) L.P. | 09/30/2019 |
|